Vactia Suomi (Finnish)
18.09.2012

VACTIA supporting a Nature supplement

VACTIA has had a notable role in sponsoring recent Nature Outlook supplement on human papillomaviruses. Front research on papillomavirus vaccines aiming to prevent the virus caused cancers, most notably cervical cancer, has been made in the VACTIA network. HPV vaccination has now been approved to the Finnish national vaccination program, and will be implemented next year. Nature Outlook supplements are a forum which the renowned Nature journal is publishing its own feature articles on important scientific topics. ”This publication is a remarkable international review of the latest knowledge in the field and future prospects of preventing papillomavirus associated cancers” says professor Matti Lehtinen, who has had an important role in these  investigations.

 

Webversion of the publication can be read at:
http://www.nature.com/nature/outlook/hpv_2012/index.html